Serge Saxonov - 04 Mar 2024 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
04 Mar 2024
Net transactions value
-$205,021
Form type
4
Filing time
06 Mar 2024, 16:12:06 UTC
Previous filing
26 Feb 2024
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $205,021 -4,660 -0.55% $44.00 842,900 04 Mar 2024 Direct F1
holding TXG Class A Common Stock 27 04 Mar 2024 See footnote F2
holding TXG Class A Common Stock 870 04 Mar 2024 See footnote F3
holding TXG Class A Common Stock 183,350 04 Mar 2024 See footnote F4
holding TXG Class A Common Stock 16,320 04 Mar 2024 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $43.9600 to $44.0401. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.